Please enter the email address you used to register, then we will send you a link to choose a new password
Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registere...
https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_08152024_ENSC_Sorensen.pdf
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $...
Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company d...
New Study to Confirm Overdose Protection Across Full Dosage Range of Breakthrough Therapy Opioid PF614-MPARSAN DIEGO, CA / ACCE...
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $...